Other/Recall·FDA Recalls, Market Withdrawals & Safety Alerts

XD Investments LLC Recalls Better Weather Fix Elixir Products Due to Undeclared Mitragynine and Mitragynine Pseuoindoxyl

MediumPublished May 9, 2026· AI-analyzed May 11, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

XD Investments LLC is voluntarily recalling roughly 448 boxes of Better Weather Fix Elixir products across all flavors and variations. FDA laboratory analysis identified the presence of undeclared Mitragynine and Mitragynine Pseudoindoxyl in the products.

Who it affects

XD Investments LLC, retailers carrying Better Weather Fix Elixir products, and quality assurance professionals responsible for botanical supplement labeling and safety testing.

Why it matters

The presence of undeclared Mitragynine (kratom alkaloids) suggests a significant failure in formulation control and labeling accuracy. Regulatory professionals should note that the presence of Mitragynine Pseudoindoxyl represents an undeclared potent derivative, which likely increases the safety risk profile and raises concerns regarding product adulteration in the eyes of the FDA.

Practical takeaway

QA and Regulatory teams should review incoming raw material specifications and finished product testing protocols for undeclared alkaloids or psychoactive compounds. Conduct a thorough audit of supply chain documentation to ensure all botanical derivatives are accurately declared on labeling.

FDA source material

XD Investments LLC of Houston, TX, is voluntarily recalling approximately 448 Boxes of Better Weather Fix Elixir products, including all flavors and variations, because FDA analysis found the products to contain undeclared Mitragynine and Mitragynine Pseudoindoxyl. (MP) is a more potent derivative o

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.